Editor's Note Machine learning (ML) models designed to predict patient mortality are falling short when it comes to identifying severe injuries that could lead to death, according to a March 27 report in TechTarget. The article focuses on research published in Nature Communications Medicine found that ML mortality prediction models…

Read More

Editor's Note Misdiagnosis, delayed treatment, and a breakdown of trust in healthcare can all result from time and resource constraints preventing proper engagement with patients—a concern that tops ECRI’s list of the most significant patient safety risks for 2025. As detailed in the global healthcare safety nonprofit’s March 10 announcement,…

Read More

Editor's Note The US Food and Drug Administration (FDA) designated Getinge’s recall of Vaporizer Sevoflurane Maquet Filling and Sevoflurane Quick-Fil and Philips’ recall of Tack Endovascular Systems as Class 1s, the most severe category indicating serious risk of injury or death. The Getinge recall is an expansion of a 2024…

Read More

Editor's Note The first study to directly compare kidney-related adverse outcomes between perioperative use of gabapentin and pregabalin shows that the former drug carries a higher risk, Renal and Urology News reported January 21. Published in Frontiers in Medicine, the study involved a trial emulation of 1,280 propensity-matched surgical patients…

Read More

Editor's Note Risk of delayed therapy and death related to Ivenix large-volume infusion pumps is prompting supplier Fresenius Kabi USA to pull a subset of the devices from the market, according to an early alert from The US Food and Drug Administration (FDA). Issued December 11, the early alert is…

Read More

Editor's Note A September 2024 study, published in the Journal of the American College of Cardiology, found that subclinical atherosclerosis progression in asymptomatic individuals is strongly linked to increased risk of death from any cause, CathLab Digest September 30 reports. The study, led by Mount Sinai Fuster Heart Hospital researchers,…

Read More

Editor's Note A recent study in JAMA Surgery showed women with hepatocellular carcinoma (HCC) were 8% less likely than men to receive a liver transplant and 6% more likely to die or be removed from the waitlist, Healio reported September 9.    The study, which analyzed 31,725 adults waitlisted for…

Read More

Editor's Note A recent study from two tertiary care centers highlighted significant sex differences in long-term outcomes after cardiac surgery, especially concerning postoperative atrial fibrillation (postopAF), MedPage August 21 reports. The study, published in JAMA Network, found that while women were less likely than men to develop postopAF following a…

Read More

Editor's Note Clinicians managing surgical patients on direct oral anticoagulants (DOACs) should adopt a different approach depending on the procedure, according to research published August 12 in JAMA Network. Used to treat patients with atrial fibrillation and venous thromboembolism, DOACs must be managed effectively to minimize risks of bleeding, researchers…

Read More

Editor's Note The “surgical pause”—a means of validating whether surgery is truly safe for patients deemed to be “frail” before starting a procedure—significantly reduces mortality rates and is changing practices at more than 50 Veterans Administration (VA) hospitals, the Pittsburgh Post-Gazette reported August 18. Developed by VA surgeons Daniel Hall…

Read More